Show results for
Refine by
Applications
- Medical cannabis solutions for regulatory pathway sector
- Medical cannabis solutions for mental health costs sector
- Compact MRI Systems for Anatomy and Morphology
- Compact MRI Systems for Cancer Research
- Medical solutions for MiniTC and mini-stem system sector
- Colovac - Flexible Endoluminal Bypass Sheath for Patients
- The mat (t) isse bioprothesis: a bio-resorbable tec (tissue engineering chamber)
- Software Solutions for Deep Mutational Scanning & Selection
- Software Solutions for COVID-19
Testing Services Targeting To Preclinical Studies Equipment & Supplies
298 equipment items found
Manufactured by:Tectonic Therapeutic, Inc. based in
AVROBIO has a preclinical research program for an investigational gene therapy for Gaucher disease type ...
Manufactured by:Anaveon AG based inBasel, SWITZERLAND
The culmination of our research is ANV419, which is in clinical development. It is a rationally engineered fusion protein that is a stable, antibody-like molecule. ...
Manufactured by:CTIBiotech based inMeyzieu, FRANCE
Using the latest tools in bioengeneering, our researchers are now printing cancer tissues in 3D. These models can be used for highly significant pre-clinical trials and can be produced in 6/48/96 well plates for high throughput ...
Manufactured by:Tectonic Therapeutic, Inc. based in
AVROBIO has a preclinical research program for a gene therapy for Pompe disease. We have shown a favorable preclinical safety and efficacy profile in a mouse model of Pompe ...
Manufactured by:CytomX Therapeutics, Inc. based inSouth San Francisco, CALIFORNIA (USA)
CX-188 is our wholly owned PD-1-targeting Probody therapeutic. As with anti-PD-L1 therapies, PD-1 monotherapy and combinations have been associated with significant toxicities. Our preclinical studies have shown that CX-188 has the potential for an improved therapeutic index relative to PD-1 antibodies. The IND for CX-188 was cleared by the FDA. Following a program and portfolio prioritization, ...
Manufactured by:Tectonic Therapeutic, Inc. based in
AVROBIO has a preclinical research program for mucopolysaccharidosis type II (MPS II), or Hunter syndrome. The program is being developed in collaboration with Brian Bigger, Ph.D., who has published favorable preclinical data in a mouse model of Hunter ...
Manufactured by:Elpiscience based inShanghai, CHINA
ES004 is a potentially best-in-class antibody targeting pan-allele signal-regulatory protein alpha (SIRPα). SIRPα is an inhibitory receptor expressed only on myeloid cells and dendritic cells. Binding of CD47 to SIRPα delivers a “don’t eat me” signal to suppress phagocytosis. Tumor cells frequently overexpress CD47 to evade macrophage-mediated destruction. To ...
Manufactured by:EMulate Therapeutics, Inc. based inBellevue, WASHINGTON (USA)
Indolor Therapeutics is feasibility (phase I) trial ready for the treatment of acute and chronic pain by the application of specific pain-managing ulRFE fields, another expression of EMulate’s Therapeutic ...
Manufactured by:InSilicoTrials Technologies based inStafford, VIRGINIA (USA)
A new in silico tool for early screening of compounds multicurrent blocking effects on a population of hiPSC-derived ...
Manufactured by:iThera Medical GmbH based inMunich, GERMANY
The RSOM Explorer P50 consists of a compact mobile cart system with a light-tight imaging chamber including a live-view camera for experiment supervision and a heated animal bed with integrated anesthesia supply. While raster-scanning the field of view, a nanosecond pulsed 532 nm laser excites the tissue. The induced ultrasound signal is detected by a broadband transducer with 50 MHz center ...
Manufactured by:Aspect Imaging Ltd. based inNashville, TENNESSEE (USA)
Enhance your research with the world’s first complete and most cost-effective permanent magnet simultaneous PET/MRI solution for preclinical research. It features the most compact and reliable MRI-compatible SiPM PET (Silicon Photo Multiplier) insert for truly simultaneous PET/MRI studies in small ...
Manufactured by:Medprin Biotech GmbH based inFrankfurt, GERMANY
100% absorbable within 7-14 days. Hemostasis in capillary, venous as well as small artery bleeding. StypCel™ works when ligation or other conventional methods are impracticable or ...
Manufactured by:Varian Medical Systems, Inc. based inPalo Alto, CALIFORNIA (USA)
Next-generation proton therapy with a smaller ...
Manufactured by:NeuroMD based inNorth Miami Beach, FLORIDA (USA)
The most advanced, FDA-cleared system to restore your lower back health and provide lasting pain relief. Equipped with pre-set, clinically studied NMES parameters, the Corrective Therapy Device® delivers proven electrical stimulation to correct the source of the pain. Get started on the path to relief during our biggest sale ever with savings of $200 and enjoy a 60-day at-home ...
by:Sorrento Therapeutics, Inc. based inSan Diego, CALIFORNIA (USA)
Sorrento utilizes a proprietary knock-out knock-in (KOKI) technology to modify normal healthy donor derived T cells to genetically engineer them to express the dimeric antigen receptor into T-cell receptor (TCR) alpha chain constant region (TRAC). In this manner, TRAC is knocked out and antigen is knocked into its locus. The Dimeric Antigen Receptor (DAR) utilizes a Fab instead of the scFv ...
by:XELTIS BV based inEindhoven, NETHERLANDS
The aXess graft is a restorative, synthetic, electrospun blood vessel for arteriovenous hemodialyisis access, overtime turning into a living vessel made of patient’s own ...
Manufactured by:Elpiscience based inShanghai, CHINA
LAG3 is an immune checkpoint receptor known to suppress T cell activation. We designed ES005 to block LAG3 ligands, including MHC class II and FGL1. Through unique epitope binding, ES005 is able to recognize human LAG3 with high affinity. In preclinical studies, ES005 inhibited tumor growth both as a monotherapy and in combination with a PD-1 ...
Manufactured by:BioCydex based inPoitiers, FRANCE
Vectisol® is dedicated to the preservation of organs, tissues and cells. This molecular complex limits the deleterious effects of the ischemia-reperfusion ...
Manufactured by:BriaCell Therapeutics Corp. based inWest Vancouver, BRITISH COLUMBIA (CANADA)
Early-Stage Preclinical Program: 30% of all human malignancies display activating RAS mutations with another 60% showing over-activity of Ras-signaling pathways. BriaCell’s novel, proprietary PKCδ inhibitors have shown activity against multiple RAS transformed tumors. This target has an attractive safety profile based on in vivo studies and knock out mouse studies. PKCδ also has ...
Manufactured by:Auris Medical AG based inBasel, SWITZERLAND
Development of Bentrio™ (AM-301) has been completed. The product has been introduced to the market, starting in selected countries of the European ...